UTI Form 144: Proposed sale of 10,000 common shares
UTI submitted a Form 144 notice for the proposed sale of Common Stock, listing 10,000 shares and an aggregate amount of $375,000.00, dated 03/04/2026 on the NYSE.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UTI submitted a Form 144 notice for the proposed sale of Common Stock, listing 10,000 shares and an aggregate amount of $375,000.00, dated 03/04/2026 on the NYSE.
The filing also lists stock awards dated 03/14/2022 for 5,246 shares and 02/22/2023 for 9,895 shares as securities to be sold.
Insights
Form 144 notifies the market of a planned sale of securities by an affiliate.
The notice lists 10,000 shares of Common Stock with an aggregate amount of $375,000.00 dated 03/04/2026. This is a regulatory disclosure under Rule 144 signaling an intended secondary sale.
Timing, method of sale, and whether sales will occur under volume limitations are not detailed here; subsequent transaction reports will show actual dispositions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does UTI's Form 144 report?
Which specific securities are listed to be sold on the Form 144?
Does the Form 144 show recent sales in the past three months?
Who receives proceeds from the proposed sale in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.